Rangering i aksjer
#38816
Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in... Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in Macclesfield, concentrates its efforts on the discovery, early-stage preclinical development, and licensing of innovative small molecule drugs. The company primarily targets significant unmet medical needs in the therapeutic areas of oncology and fibrosis. Within its oncology portfolio, Redx is progressing RXC004, a porcupine inhibitor currently undergoing Phase II clinical evaluation for treating cancers driven by Wnt-ligands. Additionally, it maintains a research collaboration with Jazz Pharmaceuticals plc, aiming to identify and advance new drug candidates for two specific cancer pathways: the Ras/Raf/MAP kinase pathway. For fibrotic conditions, Redx Pharma is developing several compounds, including RXC007, an oral selective ROCK2 inhibitor intended for the treatment of various fibrotic diseases. Its pipeline also features a gastrointestinal-targeted ROCK inhibitor specifically designed to address fibrosis associated with Crohn's disease, along with a discoidin domain receptors (DDRs) inhibitor for a range of fibrotic disorders. Furthermore, the company is developing RXC006, another porcupine inhibitor, focused on combating fibrotic illnesses such as idiopathic pulmonary fibrosis.
Aksjekurs
$0.20410523
Sist synkronisert: 2024-04-30
Handel Redx Pharma Plc (REDX)
Pris REDX pris med markedsverdi på B
Markedsverdi av Redx Pharma Plc(REDX)
Markedsverdi: $793.94K
Per August 2026 har Redx Pharma Plc en markedsverdi på $793.94K. Dette gjør Redx Pharma Plc til det 38816th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Redx Pharma Plc fra 2015 til 2026
REDX sammenlignet med topp 5 mest populære stocks
| Pris på REDX |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.470T
|
+689,007,738.91%
|
|
|
|
|
$4.501T
|
+566,948,373.25%
|
|
|
|
|
$4.185T
|
+527,141,002.73%
|
|
|
|
|
$3.687T
|
+464,435,472.68%
|
|
|
|
|
$2.849T
|
+358,892,554.71%
|
